NSDL Q2 FY2027 slides: revenue surges 35% as tech investments continue

RedHill’s RHB-204 shows bacteria-killing effect in lab studies

Investing.com · News 3m ago

AN2 Therapeutics receives FDA clearance for PV trial

Investing.com · News 3m ago

Rapport Therapeutics raises $410.7 million in stock, note sales

Investing.com · News 3m ago

Graphite One receives Ohio air permit for anode facility

Investing.com · News 3m ago

Caldera names CFO and chief legal officer ahead of merger

Investing.com · News 3m ago

TD consolidates asset management businesses under single brand

Investing.com · News 3m ago

Hornbeck Offshore secures five-year Shell contract

Investing.com · News 3m ago

Take-Two stock rises on strong GTA 6 demand in teen survey

Investing.com · Investing_news 4m ago

Trump Family-Linked Mining Venture Aims to Go Public in $2 Billion Deal

Dow Jones · Markets 8m ago

Wedbush lowers Take-Two stock price target to $280 on lower earnings

Investing.com · News 13m ago